ロード中...
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
Breast cancer remains a leading cause of cancer-related death internationally. Treatment approaches for metastatic breast cancer have evolved in recent years; however chemotherapy remains a core component for the majority of patients. Agents such as anthracyclines and taxanes have been extensively s...
保存先:
| 出版年: | Int J Womens Health |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294649/ https://ncbi.nlm.nih.gov/pubmed/25610001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S74462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|